[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545764":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":27,"locations":33,"responsibleParty":169,"collaborators":24,"id":171,"slug":172,"hasResults":173,"nctId":174,"briefTitle":175,"officialTitle":176,"acronym":24,"eligibilityCriteria":177,"healthyVolunteers":173,"sex":178,"minAge":179,"maxAge":24,"enrollmentInfo":180,"targetDuration":24,"studyType":183,"phases":184,"briefSummary":187,"conditions":188,"keywords":190,"overallStatus":36,"whyStopped":24,"lastUpdateSubmitDate":192,"lastUpdatePostDateStruct":193,"startDateStruct":196,"completionDateStruct":198,"leadSponsor":200,"locationsCount":201},{"fullName":5,"class":6},"Jacobio Pharmaceuticals Co., Ltd.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Dose escalation phase","EXPERIMENTAL","Multiple dose levels of JAB-30355 will be explored to determine the maximum tolerated dose (MTD)",[13],"Drug: JAB-30355",{"label":15,"type":10,"description":16,"interventionNames":17},"Dose expansion phase","Dose Expansion Phase will explore JAB-30355's clinical benefit and optimal tolerability in selected dose level.",[13],[19,25],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","JAB-30355","Oral administration",[9],null,{"type":20,"name":21,"description":22,"armGroupLabels":26,"otherNames":24},[15],[28],{"name":29,"role":30,"phone":31,"phoneExt":24,"email":32},"Jacobio Pharmaceuticals","CONTACT","781-918-6670","clinicaltrials@jacobiopharma.com",[34,48,59,68,77,85,94,103,114,119,124,133,142,151,160],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":24},"Research Site","RECRUITING","Denver","Colorado","80218","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-104.9847,39.73915,{"lat":46,"lon":45},{"facility":49,"status":50,"city":51,"state":52,"zip":53,"country":40,"countryCode":41,"cosmosGeoPoint":54,"geoPoint":58,"contacts":24},"Research site","TERMINATED","Lake Mary","Florida","32771",{"type":43,"coordinates":55},[56,57],-81.31784,28.75888,{"lat":57,"lon":56},{"facility":49,"status":36,"city":60,"state":61,"zip":62,"country":40,"countryCode":41,"cosmosGeoPoint":63,"geoPoint":67,"contacts":24},"St Louis","Missouri","63110",{"type":43,"coordinates":64},[65,66],-90.19789,38.62727,{"lat":66,"lon":65},{"facility":49,"status":50,"city":69,"state":70,"zip":71,"country":40,"countryCode":41,"cosmosGeoPoint":72,"geoPoint":76,"contacts":24},"Canton","Ohio","44718",{"type":43,"coordinates":73},[74,75],-81.37845,40.79895,{"lat":75,"lon":74},{"facility":49,"status":36,"city":78,"state":70,"zip":79,"country":40,"countryCode":41,"cosmosGeoPoint":80,"geoPoint":84,"contacts":24},"Cleveland","44195",{"type":43,"coordinates":81},[82,83],-81.69541,41.4995,{"lat":83,"lon":82},{"facility":35,"status":36,"city":86,"state":87,"zip":88,"country":40,"countryCode":41,"cosmosGeoPoint":89,"geoPoint":93,"contacts":24},"Nashville","Tennessee","37203",{"type":43,"coordinates":90},[91,92],-86.78444,36.16589,{"lat":92,"lon":91},{"facility":49,"status":36,"city":95,"state":96,"zip":97,"country":40,"countryCode":41,"cosmosGeoPoint":98,"geoPoint":102,"contacts":24},"Houston","Texas","77030",{"type":43,"coordinates":99},[100,101],-95.36327,29.76328,{"lat":101,"lon":100},{"facility":35,"status":36,"city":104,"state":105,"zip":106,"country":107,"countryCode":108,"cosmosGeoPoint":109,"geoPoint":113,"contacts":24},"Beijing","Beijing Municipality","100000","China","CN",{"type":43,"coordinates":110},[111,112],116.39723,39.9075,{"lat":112,"lon":111},{"facility":35,"status":36,"city":104,"state":105,"zip":115,"country":107,"countryCode":108,"cosmosGeoPoint":116,"geoPoint":118,"contacts":24},"100021",{"type":43,"coordinates":117},[111,112],{"lat":112,"lon":111},{"facility":35,"status":36,"city":104,"state":105,"zip":120,"country":107,"countryCode":108,"cosmosGeoPoint":121,"geoPoint":123,"contacts":24},"100142",{"type":43,"coordinates":122},[111,112],{"lat":112,"lon":111},{"facility":35,"status":36,"city":125,"state":126,"zip":127,"country":107,"countryCode":108,"cosmosGeoPoint":128,"geoPoint":132,"contacts":24},"Guangzhou","Guangdong","510000",{"type":43,"coordinates":129},[130,131],113.25,23.11667,{"lat":131,"lon":130},{"facility":35,"status":36,"city":134,"state":135,"zip":136,"country":107,"countryCode":108,"cosmosGeoPoint":137,"geoPoint":141,"contacts":24},"Zhengzhou","Henan","451191",{"type":43,"coordinates":138},[139,140],113.64861,34.75778,{"lat":140,"lon":139},{"facility":35,"status":36,"city":143,"state":144,"zip":145,"country":107,"countryCode":108,"cosmosGeoPoint":146,"geoPoint":150,"contacts":24},"Shenyang","Liaoning","110801",{"type":43,"coordinates":147},[148,149],123.43278,41.79222,{"lat":149,"lon":148},{"facility":35,"status":36,"city":152,"state":153,"zip":154,"country":107,"countryCode":108,"cosmosGeoPoint":155,"geoPoint":159,"contacts":24},"Jinan","Shandong","250117",{"type":43,"coordinates":156},[157,158],116.99722,36.66833,{"lat":158,"lon":157},{"facility":35,"status":36,"city":161,"state":162,"zip":163,"country":107,"countryCode":108,"cosmosGeoPoint":164,"geoPoint":168,"contacts":24},"Shanghai","Shanghai Municipality","200032",{"type":43,"coordinates":165},[166,167],121.45806,31.22222,{"lat":167,"lon":166},{"type":170,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100545764","phase-1-jab-30355-in-patients-with-advanced-solid-tumors-harboring-tp53-y220c-mutation-100545764",false,"NCT06386146","JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation","A Phase 1\u002F2a, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Activity of JAB-30355 in Adult Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation","Inclusion Criteria:\n\n* Written informed consent.\n* Participant must be ≥18 years of age at the time of signing the Informed Consent Form (ICF).\n* ECOG performance status score of 0 or 1.\n* Has been treated with at least one line of systemic therapy for that tumor type and stage.\n* Have documentation of confirmed TP53 Y220C mutation.\n* At least 1 measurable lesion per RECIST v1.1.\n* Adequate hematological, renal and hepatic function and appropriate coagulation condition.\n* Able to swallow and retain orally administered medication.\n\nExclusion Criteria:\n\n* Active brain or spinal metastases or primary CNS tumor.\n* Active infection requiring systemic treatment within 7 days.\n* Active HBV or HCV.\n* Any severe and\u002For uncontrolled medical conditions.\n* LVEF ≤50% assessed by ECHO or MUGA.\n* QTcF \\> 470 msec.","ALL","18 Years",{"count":181,"type":182},144,"ESTIMATED","INTERVENTIONAL",[185,186],"PHASE1","PHASE2","This study is to evaluate the efficacy and safety of JAB-30355 in adult participants with advanced solid tumors harboring TP53 Y220C mutation.",[189],"Solid Tumors",[191],"TP53 Y220C reactivator; TP53 Y220C mutation; P53; Tumor protein p53; TP53; Advanced solid tumors; Ovarian Cancer; JAB-30355","2026-05-20",{"date":194,"type":195},"2026-05-22","ACTUAL",{"date":197,"type":195},"2024-07-24",{"date":199,"type":182},"2027-07",{"name":5,"class":6},15]